1985
DOI: 10.1002/jobm.3620250508
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial resistance to streptothricins

Abstract: Resistance to streptothricin was studied in bacteria with different resistance mechanisms. The laboratory-induced streptothricin-resistant mutant E. coli A19 Stcr 2/2/1 showed a high level of cross-resistance to aminoglycosides and other miscoding inducing antibiotics. In contrast, aminoglycosid-resistant E. coli strains with plasmid-determined aminoglycoside modifying enzymes were sensitive to streptothricin. Enzymatic inactivation of streptothricin by acetylation was demonstrated for the streptothricin produ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

1986
1986
2021
2021

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 15 publications
0
5
0
Order By: Relevance
“…Nourseothricin (NAT) is an inhibitor of ribosomal protein synthesis produced by Streptomyces noursei that induces miscoding during translation in a wide range of prokaryotic and eukaryotic organisms. NAT resistance can be conferred by the S. noursei nat1 gene, encoding an N‐acetyltransferase that monoacetylates nourseothricin (Haupt and Thrum, 1985; Krugel et al , 1993) and has previously been used as a selectable marker in other yeast organisms (Goldstein and McCusker, 1999; McDade and Cox, 2001).…”
Section: Resultsmentioning
confidence: 99%
“…Nourseothricin (NAT) is an inhibitor of ribosomal protein synthesis produced by Streptomyces noursei that induces miscoding during translation in a wide range of prokaryotic and eukaryotic organisms. NAT resistance can be conferred by the S. noursei nat1 gene, encoding an N‐acetyltransferase that monoacetylates nourseothricin (Haupt and Thrum, 1985; Krugel et al , 1993) and has previously been used as a selectable marker in other yeast organisms (Goldstein and McCusker, 1999; McDade and Cox, 2001).…”
Section: Resultsmentioning
confidence: 99%
“…Based on the Tn5-based hyperactive in vitro transposase-based system and broadly expressed proD promoter-driven reporter expression, the toolkit should prove broadly applicable to a wide variety of Gram-negative and -positive bacterial species (38). In addition, the available nonantibiotic selectable markers encoding resistance to nourseothricin (39,40), phleomycin (41), and hygromycin provide multiple options for selection without imparting resistance to therapeutic antibiotics. Such antibiotic resistance when not normally found in pathogens under study might otherwise limit therapeutic options and is potentially proscribed under "dual use research of concern" (42) policies (http://www.phe.gov/s3/dualuse/documents/durc-policy.pdf).…”
Section: Discussionmentioning
confidence: 99%
“…Both streptothricin and nourseothricin are inactivated by acetyltransferase activity [73,92] present in extracts of their producers (Streptomyces strain V-13-1 and Streptomyces noursei, respectively). Genes encoding such activity (sta from Streptomyces lavendulae [80], another streptothricin producer; nat, formerly ntr, from S. noursei [105]) confer high-level resistance in S. lividans and the product generated by purified streptothricin acetyltransferase (STAT) has been characterized as N b -acetylstreptothricin.…”
Section: Streptothricin and Nourseothricinmentioning
confidence: 99%